HIV/AIDS Diagnostics Market Will Likely Expand at a 9.3% CAGR Between 2017 and 2025
The global HIV/AIDS diagnostics market has a handful of dominant players competing against one another. Competition is moderate in the market on account of a few products being approved for commercial use. In fact, all the products in the U.S. are used only for the purpose of research. Another factor serving to keep competition moderate is the high entry barriers to aspiring players. This is because development of diagnostic kits require a lot of research. Going forward, however, the competition...
View full press release